P4O2 is a public private initiative. People with varying risk of developing lung disease, research institutes, societies, and companies will be involved. P4O2 is a program of the NPL, which is an initiative of the NRS, supported by the ERS, Dutch Lung Foundation, NVALT, LAN, CAHAG, and patients with lung disease. SODAQ and GSK recently officially joined the P4O2 consortium. We are talking to TNO and the RIVM and companies in data management, data analysis, artificial intelligence, biotechnology (diagnostics, -omics analysis, in vitro models, wearables), and food industry. Various companies are expected to join P4O2 soon.

If you are potentially interested in joining P4O2 as a collaborator, please contact us via nrs@nrs-science.nl to make an appointment to discuss the possibilities.


Amsterdam University Medical Centers (Amsterdam UMC) - Respiratory Medicine
University of Amsterdam                        
Prof. Dr. A.H. Maitland-van der Zee (PI)
J.J.M.H. van Bragt, PharmD, MSc

VU University                                             
Prof. Dr. H.J. Bogaard

University of Groningen, University Medical Center Groningen (UMCG) - Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research
Prof. Dr. I.H Heijink
Dr. S.D. Pouwels

Maastricht University Medical Center (Maastricht UMC+) - NUTRIM School of Nutrition and Translational Research in Metabolism – department of Respiratory Medicine
Prof. Dr. A. Schols
Dr. R.C.J. Langen
Dr. R. Beijers

University Medical Center Utrecht (UMC Utrecht)
Dr. F. Mohamed Hoesein
Prof. Dr. R. Vermeulen

Utrecht University
Prof. Dr. R. Vermeulen (IRAS)
Dr. G. Downward

M. van den Heuvel, MSc

Nationaal Programma Longonderzoek
Initiative of the NRS, Lung Foundation Netherlands, LAN
Supportred by NVALT, CAHAG, ERS 


Logos NPL supporters

Are you interested in collaborating in P4O2? We would be happy to meet and discuss opportunities.
Read more
© 2020 P4O2